5th Floor, Rajapushpa Summit
Nanakramguda Rd, Financial District, Gachibowli
Hyderabad, Telangana - 500008
The Italy Patient Monitoring Market is Segmented by Type of Device, Application (Cardiology, Neurology, Respiratory, Fetal and Neonatal, Weight Management and Fitness Monitoring, and Other Applications) and End-User
The Italy Patient Monitoring Market is expected to register a CAGR of 4.9% during the forecast period, owing to the factors such as the increasing burden of chronic disorders along with the rising geriatric population and growing preference for home and remote monitoring.
According to the World Population Ageing 2019 report, in Italy population aged 65 years or over in 2019 was 13.93 million (23%) and this number is projected to reach 16.46 million (27.9%) in 2030. Thus, an increasing number of the geriatric population who are more prone to chronic diseases is expected to drive the market as this population requires monitoring devices in the management of diseases.
In addition, according to the International Diabetes Federation (IDF), as of 2020 in Italy, there are around 3,669,400 cases of diabetes in adults. The prevalence of diabetes in the adult population is 8.3%. Thus, owing to the above-mentioned factors it is expected to show significant growth over the forecast period.
As per the scope of this report, patient monitoring devices are the monitoring devices that continuously monitor the patient’s vital parameters, like blood pressure and heart rates, by using a medical monitor and collecting medical (and other) data from individuals. The Italy Patient Monitoring Market is segmented by type of device, application and end-user.
Report scope can be customized per your requirements. Click here.
The major factors driving the growth of this segment include the rising burden of chronic diseases such as cardiovascular diseases and diabetes due to lifestyle changes. According to the latest World Health Organization (WHO) data, coronary heart disease deaths in Italy was around 35,324 or 6.23% of total deaths in 2018. The age-adjusted death rate was 51.28 per 100,000 of the population. The high death rates of coronary heart disease are expected to show greater demand for hemodynamic patient monitoring devices which shows a positive impact on market growth. Thus, a high number of patients with heart diseases is expected to drive market growth over the forecast period.
To understand key trends, Download Sample Report
The Italy patient monitoring market is consolidated competitive. The companies are implementing certain strategic initiatives, such as mergers, new product launches, acquisitions, and partnerships that help them in strengthening their market position. Some of the market players are Koninklijke Philips NV, Nihon Kohden Corporation, GE Healthcare (GE Company), Abbott Laboratories, Dragerwerk AG & Co. KGaA, and others.
1.1 Study Assumptions
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Burden of Chronic Diseases due to Lifestyle Changes
4.2.2 Growing Preference for Home and Remote Monitoring
4.3 Market Restraints
4.3.1 High Cost of Technology
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Type of Device
5.1.1 Hemodynamic Monitoring Devices
5.1.2 Neuromonitoring Devices
5.1.3 Cardiac Monitoring Devices
5.1.4 Multi-parameter Monitors
5.1.5 Respiratory Monitoring Devices
5.1.6 Remote Patient Monitoring Devices
5.1.7 Other Types of Devices
5.2 By Application
5.2.4 Fetal and Neonatal
5.2.5 Weight Management and Fitness Monitoring
5.2.6 Other Applications
5.3 By End Users
5.3.1 Home Healthcare
5.3.2 Hospitals and Clinics
5.3.3 Other End Users
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 General Electric Company (GE Healthcare)
6.1.2 Nihon Kohden Corporation
6.1.3 Koninklijke Philips N.V.
6.1.4 Dragerwerk AG & Co. KGaA
6.1.5 Abbott Laboratories
6.1.6 Medtronic Plc
6.1.7 Edwards Lifesciences Corporation
6.1.8 OMRON Corporation
6.1.9 Dexcom, Inc
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments